Celldex Therapeutics
Price & Volume
Stats
See moreOpen | $27.70 |
Previous Close | $27.35 |
Day Range | $27.48-$28.05 |
52W Range | $14.40-$30.50 |
Market Cap | $1.8B |
Shares Short | 6M |
Financials
See moreRevenue (12 Mos) | $2.5M |
Revenue Growth (YoY) | -70.8% |
Gross Profit (12 Mos) | -$214M |
Diluted EPS | -$3.38 |
News
See moreYahoo Finance • 19 days ago
Barclays Lifts PT on Celldex Therapeutics (CLDX) to $24 From $21
Yahoo Finance • last month
Celldex Initiates Global Registrational Phase 3 Program of Barzolvolimab in Cold Urticaria and Symptomatic Dermographism
Yahoo Finance • 2 months ago
Celldex Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Yahoo Finance • 2 months ago
Celldex Announces Appointment of Teri Lawver as Chief Commercial Officer
About
CEO | Mr. Anthony S. Marucci M.B.A. |
CFO | Mr. Sam Martin CPA |
Address | Perryville III Building, Hampton, NJ, United States, 08827 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 186 |
